Home / Health / Rare Gene Mutation Fuels Aggressive Prostate Cancer
Rare Gene Mutation Fuels Aggressive Prostate Cancer
10 Jul
Summary
- A rare genetic mutation in the CDK12 gene is linked to aggressive prostate cancer.
- Individuals with this inherited mutation developed metastatic cancer by diagnosis.
- Discovery could help identify at-risk families for earlier screening.
Scientists have identified a rare inherited genetic mutation in the CDK12 gene that appears to be linked to aggressive forms of prostate cancer. This discovery offers a new avenue for identifying individuals and families at high risk.
In a study involving over 4,500 individuals with aggressive prostate cancer, researchers found five unrelated men who had inherited CDK12 mutations. Strikingly, all of them had developed metastatic prostate cancer by the time they were diagnosed, typically between the ages of 44 and 62.
This breakthrough, published in Cancer Discovery, suggests that CDK12 mutations could become an important warning sign, similar to BRCA mutations. The findings support adding CDK12 to standard genetic testing panels for hereditary prostate cancer, potentially enabling earlier screening and intervention when curative treatment options are available.
The study also noted potential links between inherited CDK12 mutations and ovarian cancer, as some patients had family histories of this disease. Researchers express hope for a future where early detection prevents deaths from cancers associated with these mutations.
